Genelux (GNLX) Stock Price
Genelux Price
Revenue at Genelux has contracted by 91.0% per year over the past 3 years to 8,000.00 USD. Genelux's net margin stands at -401,812.5%, down from -47.0% several years earlier.
Genelux stock price
Genelux business model & stock analysis
Frequently asked questions about Genelux
11 analysts currently rate the Genelux stock: 10 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Genelux share trades at 2.23 EUR (2.50 USD).
The Genelux share (GNLX) is listed on 1 stock exchanges, including: NASDAQ (GNLX).
The revenue cannot currently be calculated for Genelux.
The expected profit of Genelux is -36.44 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Genelux is currently -2.55. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Genelux stock.
The P/S cannot be calculated for Genelux currently.
The Eulerpool Quality Score for Genelux is 2/10.
The ISIN of Genelux is US36870H1032. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Genelux is GNLX. The ticker symbol is used to trade Genelux shares on the stock exchange.
Genelux stock
Genelux Peer Group
Genelux Ticker
Genelux FIGI
All fundamentals and in-depth analysis of Genelux
Our stock analysis for Genelux stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genelux. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.